Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Intangibles (2016 - 2026)

Bio-Techne has reported Intangibles over the past 17 years, most recently at $897.2 million for Q4 2025.

  • For Q4 2025, Intangibles rose 94.59% year-over-year to $897.2 million; the TTM value through Dec 2025 reached $897.2 million, up 94.59%, while the annual FY2025 figure was $365.6 million, 450.6% up from the prior year.
  • Intangibles for Q4 2025 was $897.2 million at Bio-Techne, up from $350.1 million in the prior quarter.
  • Over five years, Intangibles peaked at $1.1 billion in Q1 2025 and troughed at $22.7 million in Q1 2023.
  • A 5-year average of $491.8 million and a median of $534.6 million in 2023 define the central range for Intangibles.
  • Biggest five-year swings in Intangibles: soared 12219.36% in 2021 and later tumbled 95.88% in 2023.
  • Year by year, Intangibles stood at $616.0 million in 2021, then decreased by 11.53% to $544.9 million in 2022, then increased by 1.04% to $550.6 million in 2023, then fell by 16.26% to $461.1 million in 2024, then skyrocketed by 94.59% to $897.2 million in 2025.
  • Business Quant data shows Intangibles for TECH at $897.2 million in Q4 2025, $350.1 million in Q3 2025, and $365.6 million in Q2 2025.